Drugs Made In America Acquisition Corp
DMAAU10.490USD
-0.090-0.85%
收盘 11/04, 16:00（美东）报价延迟15分钟
0.00总市值
--市盈率 TTM
关于 Drugs Made In America Acquisition Corp 公司
Drugs Made In America Acquisition Corp. 是一家空白支票公司。该公司成立为豁免公司，旨在与一家或多家企业进行合并、股份交换、资产收购、股份购买、资本重组、重组或其他类似的业务合并。该公司寻找潜在目标企业的努力不会局限于特定行业或地理区域，尽管该公司打算专注于寻找制药行业的业务合并目标。
Drugs Made In America Acquisition Corp简介
公司代码DMAAU
公司名称Drugs Made In America Acquisition Corp
上市日期Jan 28, 2025
CEOMs. Lynn Stockwell
员工数量- -
证券类型Unit
年结日- -
公司地址1 East Broward Boulevard
城市FT LAUDERDALE
上市交易所NASDAQ Global Market Consolidated
国家United States of America
邮编33301
电话19548703099
网址
公司代码DMAAU
上市日期Jan 28, 2025
CEOMs. Lynn Stockwell
Drugs Made In America Acquisition Corp公司高管
名称
名称/职务
职务
持股
持股变动
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director Nominee
Independent Director Nominee
--
--
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Mr. Glenn C. Worman
Mr. Glenn C. Worman
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Catherine Do
Dr. Catherine Do
Independent Director Nominee
Independent Director Nominee
--
--
名称
名称/职务
职务
持股
持股变动
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director Nominee
Independent Director Nominee
--
--
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Mr. Glenn C. Worman
Mr. Glenn C. Worman
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Catherine Do
Dr. Catherine Do
Independent Director Nominee
Independent Director Nominee
--
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 5月17日 周六
更新时间: 5月17日 周六
持股股东
股东类型
持股股东
持股股东
占比
Drugs Made In America Acquisition LLC
17.88%
RiverNorth Capital Management LLC
1.79%
Context Capital Management LLC
1.07%
Wolverine Asset Management, LLC
0.55%
Bulldog Investors, LLP
0.24%
其他
78.46%
持股股东
持股股东
占比
Drugs Made In America Acquisition LLC
17.88%
RiverNorth Capital Management LLC
1.79%
Context Capital Management LLC
1.07%
Wolverine Asset Management, LLC
0.55%
Bulldog Investors, LLP
0.24%
其他
78.46%
股东类型
持股股东
占比
Corporation
17.88%
Investment Advisor/Hedge Fund
2.25%
Hedge Fund
1.68%
Research Firm
0.20%
Investment Advisor
0.08%
其他
77.91%
机构持股
更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
19
986.13K
4.21%
-2.44M
2025Q2
20
7.49M
31.98%
+6.93M
2025Q1
20
7.60M
32.43%
+7.41M
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Drugs Made In America Acquisition LLC
4.19M
17.88%
+4.19M
--
Feb 18, 2025
RiverNorth Capital Management LLC
420.50K
1.79%
--
--
Jun 30, 2025
Context Capital Management LLC
250.00K
1.07%
--
--
Jun 30, 2025
Wolverine Asset Management, LLC
130.00K
0.55%
--
--
Jun 30, 2025
Bulldog Investors, LLP
57.30K
0.24%
-72.96K
-56.01%
Jun 30, 2025
Clear Street LLC
45.92K
0.2%
+40.07K
+685.09%
Jun 30, 2025
Robinson Capital Management, LLC
30.00K
0.13%
+20.00K
+200.00%
Jun 30, 2025
Tuttle Capital Management, LLC
20.00K
0.09%
-20.00K
-50.00%
Jun 30, 2025
UBS Financial Services, Inc.
18.39K
0.08%
+107.00
+0.59%
Jun 30, 2025
Citadel Advisors LLC
14.03K
0.06%
-1.73K
-10.96%
Jun 30, 2025
查看更多
持股ETF
更新时间: 11月2日 周日
更新时间: 11月2日 周日
机构名称
占比
SPAC and New Issue ETF
2.51%
RiverNorth Enhanced Pre-Merger SPAC ETF
0.49%
CrossingBridge Pre-Merger SPAC ETF
0%
SPAC and New Issue ETF
占比2.51%
RiverNorth Enhanced Pre-Merger SPAC ETF
占比0.49%
CrossingBridge Pre-Merger SPAC ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
